Back to Directory
Last Updated: 04/06/2026
Closed Loop Medicine
Cambridge
Founded 2017
AI-enabled personalised dosing for drug-digital combination therapies
Closed Loop Medicine develops combination products integrating pharmaceutical therapies with AI-powered digital companions to personalise drug dosing for chronic conditions.
Its platform applies pharmacometric modelling and patient response data to optimise treatment regimens.
The pipeline includes co-packaged drug and software-as-a-medical-device products for insomnia and hypertension, and a personalised GLP-1 dosing platform for obesity launched in the US in 2025.